Natàlia Lloveras

Outcome and Prognostic Factors in Patients with Hematologic Malignancies Admitted to the Intensive Care Unit: A Single-Center Experience

Christelle Ferrá, Pilar Marcos, Maite Misis et al. · International Journal of Hematology · 2007 · 70 citations

Critical Care Management, Prognostic Factors, Critical Care Medicine +11

Visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with adalimumab

Anna Moltó, Lourdes Mateo, Natàlia Lloveras et al. · Joint Bone Spine · 2010 · 33 citations

Inflammation, Rheumatology, Rheumatoid Disorder +10

Kinetics of the CTLA-4 isoforms expression after T-lymphocyte activation and role of the promoter polymorphisms on CTLA-4 gene transcription

Arianne Pérez-García, Gemma Osca‐Gelis, Anna Bosch-Vizcaya et al. · Human Immunology · 2013 · 28 citations

Immunogenetics, Transcriptional Regulation, Ctla-4 Gene Transcription +12

Donor CTLA-4 Genotype Influences Clinical Outcome after T Cell-Depleted Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Identical Sibling Donors

Anna Bosch-Vizcaya, Arianne Pérez-García, Salut Brunet et al. · Biology of Blood and Marrow Transplantation · 2011 · 20 citations · Full text

Is survival in myeloid malignancies really improving? A retrospective 15-year population-based study

Gemma Osca‐Gelis, Montserrat Puig-Vives, Marc Sáez et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2014 · 11 citations

Hematological Malignancy, Chronic Myeloid Leukemia, Oncology +8